GoodRx Holdings (GDRX) Long-Term Debt Repayments (2019 - 2026)

GoodRx Holdings' Long-Term Debt Repayments history runs 8 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, Long-Term Debt Repayments changed 0.0% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $5.0 million (down 99.21% YoY), while the FY2025 annual figure was $5.0 million, down 99.22% from the prior year.
• Long-Term Debt Repayments came in at $1.2 million for Q1 2026 at GoodRx Holdings, roughly flat from $1.2 million in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $633.8 million in Q3 2024 to a low of -$1000.0 in Q4 2023.
• A 5-year average of $41.1 million and a median of $1.8 million in 2022 frame the typical range for Long-Term Debt Repayments.
• Across the five-year window, Long-Term Debt Repayments plunged 100.06% in 2023 and jumped 35970.86% in 2024, its largest moves.
• GoodRx Holdings' Long-Term Debt Repayments stood at $1.8 million in 2022, then slumped by 100.06% to -$1000.0 in 2023, then soared by 63376600.0% to $633.8 million in 2024, then plunged by 99.8% to $1.2 million in 2025, then changed by 0.0% to $1.2 million in 2026.
• According to Business Quant data, Long-Term Debt Repayments over the past three periods registered $1.2 million, $1.2 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison